Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PepGen Inc. Director's Dealing 2024

Jun 13, 2024

33898_dirs_2024-06-13_cfb553e8-1fde-40d7-bd3e-a00cb15b1f20.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PepGen Inc. (PEPG)
CIK: 0001835597
Period of Report: 2024-06-11

Reporting Person: Mellion Michelle L (Chief Medical Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-06-11 Common Stock M 500 $10.21 Acquired 500 Direct
2024-06-11 Common Stock S 500 $18.044 Disposed 0 Direct
2024-06-12 Common Stock M 1086 $10.21 Acquired 1086 Direct
2024-06-12 Common Stock S 1086 $18.0614 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-06-11 Stock Option (Right to Buy) $10.21 M 500 Disposed 2032-06-30 Common Stock (500) Direct
2024-06-12 Stock Option (Right to Buy) $10.21 M 1086 Disposed 2032-06-30 Common Stock (1086) Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: This stock option vests over four years following the vesting commencement date (April 4, 2022) with 25% of such shares vesting on the first anniversary of the vesting commencement date, and the remaining shares vesting in 36 equal monthly installments, subject to continued service through each vesting date.